Search

Your search keyword '"Ding, Erin"' showing total 6 results
Start Over Author "Ding, Erin" Publisher sage publications
6 results on '"Ding, Erin"'

1. Prevalence and correlates of sexual concerns and associated distress among women living with HIV in Canada

Author

Carter, Allison, primary, Gormley, Becky, additional, Muchenje, Marvelous, additional, Zhu, Denise, additional, Patterson, Sophie, additional, Kestler, Mary, additional, Hankins, Catherine, additional, Logie, Carmen H, additional, Brotto, Lori A, additional, Tharao, Wangari, additional, Lee, Melanie, additional, Li, Jenny, additional, Ding, Erin, additional, de Pokomandy, Alexandra, additional, Loutfy, Mona, additional, and Kaida, Angela, additional

Published
2022
Full Text
View/download PDF

2. Impact of Canadian human immunodeficiency virus non-disclosure case law on experiences of violence from sexual partners among women living with human immunodeficiency virus in Canada: Implications for sexual rights

Author

Patterson, Sophie, primary, Nicholson, Valerie, additional, Gormley, Rebecca, additional, Carter, Allison, additional, Logie, Carmen H, additional, Closson, Kalysha, additional, Ding, Erin, additional, Trigg, Jason, additional, Li, Jenny, additional, Hogg, Robert, additional, de Pokomandy, Alexandra, additional, Loutfy, Mona, additional, and Kaida, Angela, additional

Published
2022
Full Text
View/download PDF

3. Help-Seeking to Cope With Experiences of Violence Among Women Living With HIV in Canada

Author

Gormley, Rebecca, primary, Nicholson, Valerie, additional, Parry, Rebeccah, additional, Lee, Melanie, additional, Webster, Kath, additional, Sanchez, Margarite, additional, Cardinal, Claudette, additional, Li, Jenny, additional, Wang, Lu, additional, Balleny, Rosa, additional, de Pokomandy, Alexandra, additional, Loutfy, Mona, additional, Kaida, Angela, additional, Abdul-Noor, Rahma, additional, Anema, Aranka, additional, Angel, Jonathan, additional, Bakombo, Dada Mamvula, additional, Barry, Fatimatou, additional, Bauer, Greta, additional, Beaver, Kerrigan, additional, Boucher, Marc, additional, Boucoiran, Isabelle, additional, Brophy, Jason, additional, Brotto, Lori, additional, Burchell, Ann, additional, Carter, Allison, additional, Cioppa, Lynne, additional, Conway, Tracey, additional, Côté, José, additional, Cotnam, Jasmine, additional, d’Ambrumenil, Cori, additional, Dayle, Janice, additional, Ding, Erin, additional, Dubuc, Danièle, additional, Duddy, Janice, additional, Fernet, Mylène, additional, Fraleigh, Annette, additional, Frank, Peggy, additional, Gagnier, Brenda, additional, Gagnon, Marilou, additional, Gahagan, Jacqueline, additional, Gasingirwa, Claudine, additional, Gataric, Nada, additional, Gormley, Rebecca, additional, Greene, Saara, additional, Groleau, Danielle, additional, Guerlotté, Charlotte, additional, Hart, Trevor, additional, Hankins, Catherine, additional, Hawa, Roula, additional, Heer, Emily, additional, Hogg, Robert S., additional, Howard, Terry, additional, Islam, Shazia, additional, Jean-Gilles, Joseph, additional, Jefferis, Hermione, additional, Jones, Evin, additional, Kaushic, Charu, additional, Kazemi, Mina, additional, Kestler, Mary, additional, Kiboyogo, Maxime, additional, Klein, Marina, additional, Kronfli, Nadine, additional, Kwaramba, Gladys, additional, Lacasse, Gary, additional, Lacombe-Duncan, Ashley, additional, Lee, Rebecca, additional, Lima, Viviane, additional, Lloyd-Smith, Elisa, additional, Logie, Carmen, additional, Maan, Evelyn, additional, Martel-Lafrenière, Valérie, additional, Martin, Carrie, additional, Masching, Renee, additional, Massie, Lyne, additional, Medjuck, Melissa, additional, Ménard, Brigitte, additional, Miller, Cari L., additional, Mitchell, Judy, additional, Mondragon, Gerardo, additional, Money, Deborah, additional, Monteith, Ken, additional, Muchenje, Marvelous, additional, Mukandamutsa, Florida, additional, Ndung’u, Mary, additional, O’Brien, Kelly, additional, O’Brien, Nadia, additional, Ogilvie, Gina, additional, Ogunnaike-Cooke, Susanna, additional, Otis, Joanne, additional, Patterson, Sophie, additional, Paul, Angela, additional, Peltier, Doris, additional, Pick, Neora, additional, Pierre, Alie, additional, Powis, Jeff, additional, Proulx-Boucher, Karène, additional, Quan, Corinna, additional, Rana, Jesleen, additional, Roth, Eric, additional, Rouleau, Danielle, additional, Rouleau, Geneviève, additional, Rueda, Sergio, additional, Salters, Kate, additional, Sandre, Roger, additional, Sas, Jacquie, additional, Savoie, Édénia, additional, Sereda, Paul, additional, Smith, Stephanie, additional, Summers, Marcie, additional, Tharao, Wangari, additional, Tom, Christina, additional, Tremblay, Cécile, additional, Trigg, Jason, additional, Trottier, Sylvie, additional, Underhill, Angela, additional, Wagner, Anne, additional, Walmsley, Sharon, additional, Wang, Clara, additional, Wobeser, Wendy, additional, Wozniak, Denise, additional, Yudin, Mark, additional, Zhang, Wendy, additional, and Zhu, Julia, additional

Published
2021
Full Text
View/download PDF

4. Post-marketing experience with nevirapine extended release (XR) tablets: effectiveness and tolerability in a population-based cohort in British Columbia, Canada

Author

Lepik, Katherine J, primary, Yip, Benita, additional, McGovern, Rachel A, additional, Ding, Erin, additional, Nohpal, Adriana, additional, Watson, Birgit E, additional, Toy, Junine, additional, Akagi, Linda, additional, Harrigan, P Richard, additional, Moore, David M, additional, Hogg, Robert S, additional, Montaner, Julio SG, additional, and Barrios, Rolando, additional

Published
2014
Full Text
View/download PDF

5. Transition from Pediatric to Adult HIV Care for Young Women Living with HIV.

Author

Kennedy VL, Mellor KL, Brophy J, Bitnun A, Alimenti A, Kakkar F, Logie CH, Webster K, Proulx-Boucher K, Ding E, Jabbari S, Kaida A, de Pokomandy A, and Loutfy M

Subjects
Canada epidemiology, Cohort Studies, Female, Humans, Longitudinal Studies, Surveys and Questionnaires, Young Adult, HIV Infections epidemiology, HIV Infections therapy, Transition to Adult Care
Abstract

Transitioning from pediatric to adult care is a complicated process for youth with chronic illnesses. This study elucidates the unique factors affecting transition preparedness and perception of adult HIV care among a cohort of young women with HIV. Between 2013 and 2015, 48 women with HIV, who had experience with pediatric HIV care, were enrolled in a large Canadian cohort study. Variables were self-reported during peer-administered surveys. Only 60% reported feeling prepared for transition. Having never had contact with child protection services ( P = .049), never been in foster care ( P = .011), never been in a group home ( P = .036), reporting a higher current CD4 count ( P = .033), and reporting a younger ideal age for transition ( P = .041) were associated with transition preparedness. Eighty-four percent reported equivalent or better HIV care following transition. Correlates of equivalent/better care following transition included lower personal income ( P = .023), higher CD4 count ( P = .021), care by an adult infectious diseases specialist ( P = .002), and transition preparedness ( P = .005). Our findings highlight the importance of adequate transition preparation and its effect on perception of care following transition.

Published
2020
Full Text
View/download PDF

6. Post-marketing experience with nevirapine extended release (XR) tablets: effectiveness and tolerability in a population-based cohort in British Columbia, Canada.

Author

Lepik KJ, Yip B, McGovern RA, Ding E, Nohpal A, Watson BE, Toy J, Akagi L, Harrigan PR, Moore DM, Hogg RS, Montaner JS, and Barrios R

Subjects
Adult, Anti-HIV Agents adverse effects, Anti-HIV Agents pharmacokinetics, Antiretroviral Therapy, Highly Active, British Columbia epidemiology, Cohort Studies, Drug Monitoring, Female, Follow-Up Studies, HIV Infections epidemiology, HIV Infections virology, Humans, Male, Medication Adherence, Middle Aged, Nevirapine adverse effects, Nevirapine pharmacokinetics, Population Surveillance, Retreatment, Tablets, Treatment Outcome, Viral Load, Anti-HIV Agents administration & dosage, Delayed-Action Preparations, HIV Infections drug therapy, HIV-1, Nevirapine administration & dosage, Product Surveillance, Postmarketing
Abstract

Background: Nevirapine 400 mg extended release tablets (nevirapine-XR) are a once-daily alternative to nevirapine 200 mg immediate release tablets (nevirapine-IR). Study objectives were to describe the effectiveness and tolerability of nevirapine-XR in clinical practice and, for patients who switched from once daily 2×200 mg nevirapine-IR to nevirapine-XR, compare virological suppression and plasma nevirapine concentrations during each treatment period., Methods: HIV-1-infected adults entered the study cohort if they initiated nevirapine-XR in British Columbia (BC) Canada between 1 April 2012 and 30 September 2012 and were followed until 30 September 2013. Demographic and clinical variables were abstracted from the BC Centre for Excellence in HIV/AIDS databases. Patients who switched from once daily nevirapine-IR to nevirapine-XR were monitored for 6 months pre- and post-switch with comparison of virological suppression (McNeamer's test) and median random plasma nevirapine concentrations (Wilcoxon-Mann-Whitney test) in each period., Results: The 536 nevirapine-XR-treated patients were 96% male, median (IQR) age 49.9 (44.0-56.9) years. Median follow-up was 15.6 (14.7-16.5) months, with 474/536 (88%) maintaining virological suppression. Emergent drug resistance developed in 5/536 (1%), adverse drug reactions in 17/536 (3%) and, although 31/536 (6%) reported 'whole' tablets in their stools, this was not associated with adverse outcomes. Among the 305 patients who switched from nevirapine-IR to nevirapine-XR, median (IQR) random plasma nevirapine concentration was higher during nevirapine-IR 5,000 (3,690-6,090) ng/ml than nevirapine-XR 3,930 (3,050-5,150) ng/ml (P<0.001), but there was no difference in virological suppression, 89% and 87% respectively (P=0.414)., Conclusions: This post-marketing study affirms the effectiveness and tolerability of nevirapine-XR as an alternative to nevirapine-IR in adults.

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results